6533b852fe1ef96bd12ab552

RESEARCH PRODUCT

Snps in Angiogenic Factors As Predictive Markers for Outcome in Patients (P) with Advanced Non-Squamous Nsclc (NS-NSCLC) Treated with Carboplatin, Paclitaxel (CP) and Bevacizumab (BEV). Final Results of Angiomet Spanish Lung Cancer Group Trial

Rosa RosellOscar JuanB. Massuti SuredaJ. De CastroD. Rodriguez AbreuJose-luis Gonzalez-larribaManuel DomineM. Provencio PullaEloisa Jantus-lewintreCarlos Camps

subject

Oncologymedicine.medical_specialtyGroup trialPredictive markerBevacizumabbusiness.industryHematologymedicine.diseaseCarboplatin/paclitaxelCarboplatinchemistry.chemical_compoundOncologychemistryPaclitaxelNon squamousInternal medicinemedicineLung cancerbusinessmedicine.drughttps://doi.org/10.1093/annonc/mdv045.02